MedPath

The study of postoperative intravenous patient-controlled (iv-PCA) analgesia used by oxycodone for Japanese Patients

Not Applicable
Completed
Conditions
malignant tumor
Registration Number
JPRN-UMIN000014951
Lead Sponsor
Jichi Medical University Hospital
Brief Summary

We terminated trial with no registered cases.There are two reasons for discontinuation. 1)Decreasing of candidate cases by the change of operating methods and postoperative management (many cases go back to ward directly without monitoring by artery-line that can use as blood sampling line) 2)By enactment of Clinical Trials Act, the usage restriction of oxycodone in this study arise (the possibility for regarding usage as Off-label use)

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
0
Inclusion Criteria

Not provided

Exclusion Criteria

1.Difficult patient to obtain consent or judge efficacy by mental disease or symptom. 2.Contrradicated cases for oxycodene hydrochloride (severe respiratory supression, COPD, heart failure, asthma attack, ileus, diarrhea). 3.The value of Hb is under 8mg/dl when the patient entersj intensive care unit. 4.The patient is judged to require blood transfusion after operation. 5.Also, the doctor determine the patient is inadequate to attend the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement of pain
Secondary Outcome Measures
NameTimeMethod
respiratory depression, nausea, vomiting, itching, change of drug concentration between before and after hemodialysis
© Copyright 2025. All Rights Reserved by MedPath